Skip to content

Clinical evaluation of Hyprost capsules in the management of Benign Prostatic Hyperplasia

Clinical evaluation of Hyprost capsules in the management of Benign Prostatic Hyperplasia with or without LUTS- An open labeled, randomized, clinical trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053675
Enrollment
150
Registered
2023-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N40- Benign prostatic hyperplasia

Interventions

None listed

Sponsors

Zoetic Ayurevedics Pvt. Ltd. Ahmedabad, Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of BPH. Grade 1 to Grade 3 BPH Weight of prostate gland-30-85 g Patient with Sr. PSA value Uroflomerty with peak flow rate between 10-15ml /sec Patients with IPSS Score 0-35 (complete range taken)

Exclusion criteria

Exclusion criteria: Age below 40 years. Patients of malignancy, congenital deformities of urogenital tract or any abdomino- pelvic pathology other than BPH. Patients of uncontrolled Diabetes mellitus (FBS: >140mg/dl, PPBS: >180mg/dl) Patient of Uncontrolled Hypertension ICD-10(BP >140/90 mm of Hg) Known case of cardiac diseases like IHD, MI, CAD. Congenital deformities of urogenital tract or any abdomino- pelvic pathology other than BPH. Systemic diseases like Tuberculosis, Paralysis, Parkinsonism history of MI, etc. will be excluded. Patients with history of catherization, retention, hydronephrosis or impaired kidney function will be excluded. Patients with USG findings of PVRU > 100ml Patients with evidence of Prostatic malignancy

Design outcomes

Primary

MeasureTime frame
Relieve in Sign and symptoms of LUTSTimepoint: After completion of 60 days intervention

Secondary

MeasureTime frame
Reduce size of prostateTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Tukaram S Dudhamal

Department of Shalya Tantra, ITRA, Jamnagar

dudhamal@itra.edu.in9428671939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026